Capula Management LTD Bristol Myers Squibb CO Put Options Transaction History

Capula Management LTD

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.76 Million - $1.95 Million	27,600 Added 16.01%	200,000 $12.8 Million
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $9.3 Million - $10.6 Million	-141,600 Reduced 45.1%	172,400 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $5.95 Million - $7.05 Million	86,900 Added 38.27%	314,000 $22.6 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $15,652 - $9.25 Million	-120,400 Reduced 34.65%	227,100 $16.1 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $181,550 - $199,950	-2,500 Reduced 0.71%	347,500 $26.8 Million
Q1 2022 May 17, 2022	BUY	$61.48 - $73.72 $21.5 Million - $25.8 Million	350,000 New	350,000 $25.6 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $6.92 Million - $8.07 Million	-129,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $5.33 Million - $6.24 Million	90,000 Added 230.18%	129,100 $7.64 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $563,381 - $613,522	-9,100 Reduced 18.88%	39,100 $2.59 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $9.62 Million - $10.8 Million	-162,200 Reduced 77.09%	48,200 $3.04 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $2.93 Million - $3.32 Million	50,700 Added 31.75%	210,400 $13.1 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $10.4 Million - $12.2 Million	-190,300 Reduced 54.37%	159,700 $9.39 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $16.2 Million - $23.6 Million	350,000 New	350,000 $19.5 Million

2,536

1.46B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.